Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs476141
rs476141
LINC02774
A 0.800 GeneticVariation GWASDB Genome-wide meta-analysis for severe diabetic retinopathy. 21441570

2011
dbSNP: rs476141
rs476141
LINC02774
A 0.800 GeneticVariation GWASCAT Genome-wide meta-analysis for severe diabetic retinopathy. 21441570

2011
dbSNP: rs4787008
rs4787008
RBFOX1
G 0.800 GeneticVariation GWASCAT Genome-wide meta-analysis for severe diabetic retinopathy. 21441570

2011
dbSNP: rs4787008
rs4787008
RBFOX1
G 0.800 GeneticVariation GWASDB Genome-wide meta-analysis for severe diabetic retinopathy. 21441570

2011
dbSNP: rs9866141
rs9866141
LOC101928236
T 0.800 GeneticVariation GWASCAT Genome-wide meta-analysis for severe diabetic retinopathy. 21441570

2011
dbSNP: rs9866141
rs9866141
LOC101928236
T 0.800 GeneticVariation GWASDB Genome-wide meta-analysis for severe diabetic retinopathy. 21441570

2011
dbSNP: rs9362054
rs9362054
LINC01611 ; LOC107986620
0.710 GeneticVariation BEFREE <b>Results:</b> The SNPs rs9362054 near the <i>CEP162</i> gene and rs4462262 near the <i>UBE2D1</i> gene were associated with DR (OR = 1.66, <i>p</i> = 0.001; OR = 1.37, <i>p</i> = 0.031; respectively), and rs12219125 near the <i>PLXDC2</i> gene was associated (suggestive) with CAD (OR = 2.26, <i>p</i> = 0.034). 31130920

2019
dbSNP: rs9362054
rs9362054
LINC01611 ; LOC107986620
T 0.710 GeneticVariation GWASCAT A genome-wide association study for diabetic retinopathy in a Japanese population: potential association with a long intergenic non-coding RNA. 25364816

2014
dbSNP: rs114790220
rs114790220 		0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs11662496
rs11662496 		0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs11771617
rs11771617 		0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs12656571
rs12656571
MAN2A1
0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs142610219
rs142610219
LOC107986902
0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs148995025
rs148995025
LINC02196
0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs184340784
rs184340784 		0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs200295620
rs200295620 		0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs202069793
rs202069793
LOC107987105
0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs2104455
rs2104455 		0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs2300993
rs2300993
MAN2A1
0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs61741249
rs61741249
LOC105375610
0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs74152685
rs74152685 		0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs75360147
rs75360147
SLC28A3
0.700 GeneticVariation GWASCAT Multiethnic Genome-Wide Association Study of Diabetic Retinopathy Using Liability Threshold Modeling of Duration of Diabetes and Glycemic Control. 30487263

2019
dbSNP: rs11018670
rs11018670 		G 0.700 GeneticVariation GWASCAT In the meta-analysis using multiple Caucasian cohorts (excluding GoDARTS), rs10765219 and rs11018670 showed associations for diabetic retinopathy (p = 0.003 and 0.007, respectively), while the p value of rs3913535 was not significant (p = 0.429). 30178632

2018
dbSNP: rs3913535
rs3913535
NOX4
C 0.700 GeneticVariation GWASCAT In the meta-analysis using multiple Caucasian cohorts (excluding GoDARTS), rs10765219 and rs11018670 showed associations for diabetic retinopathy (p = 0.003 and 0.007, respectively), while the p value of rs3913535 was not significant (p = 0.429). 30178632

2018
dbSNP: rs9896052
rs9896052 		A 0.700 GeneticVariation GWASCAT Only rs9896052 (p = 6.55 × 10(-5)) was associated with sight-threatening diabetic retinopathy in both the type 2 (p = 0.035) and the type 1 (p = 0.041) replication cohorts, as well as in the Indian cohort (p = 0.016). 26188370

2015